​

Longboard Pharmaceuticals (LBPH) Revenue & Revenue Breakdown

OverviewForecastOwnershipFinancialsChartTranscripts

Longboard Pharmaceuticals Revenue Highlights

00

Longboard Pharmaceuticals Revenue by Period

Longboard Pharmaceuticals Revenue by Year

DateRevenueChange
2023-12-31-100.00%
2022-12-31-100.00%
2021-12-31-100.00%
2020-12-31--

Longboard Pharmaceuticals generated - in revenue during NA 2023, up 100.00% compared to the previous quarter, and up 0.00% compared to the same period a year ago.

Longboard Pharmaceuticals Revenue by Quarter

DateRevenueChange
2024-09-30-100.00%
2024-06-30-100.00%
2024-03-31--100.00%
2023-12-31$8.00K100.00%
2023-09-30-100.00%
2023-06-30-100.00%
2023-03-31-100.00%
2022-12-31-100.00%
2022-09-30-100.00%
2022-06-30-100.00%
2022-03-31-100.00%
2021-12-31-100.00%
2021-09-30-100.00%
2021-06-30-100.00%
2021-03-31-100.00%
2020-12-31-100.00%
2020-09-30-100.00%
2020-06-30-100.00%
2020-03-31--

Longboard Pharmaceuticals generated - in revenue during Q3 2024, up 100.00% compared to the previous quarter, and up NaN% compared to the same period a year ago.

Longboard Pharmaceuticals Peer Comparison by Revenue

TickerCompanyLast Year RevenueLast Quarter Revenue
HOWLWerewolf Therapeutics$19.94M$1.14M
IKNAIkena Oncology$9.16M-
STOKStoke Therapeutics$8.78M$4.89M
ASMBAssembly Biosciences$7.16M$6.84M
MOLNMolecular Partners$7.04M$2.74M
MNOVMediciNova$1.00M-
ANEBAnebulo Pharmaceuticals--
DSGNDesign Therapeutics--
CCCCC4 Therapeutics--
NXTCNextCure--
TILInstil Bio--
CELCCelcuity--
SNSESensei Biotherapeutics--
GLUEMonte Rosa Therapeutics-$4.70M
EWTXEdgewise Therapeutics--
NUVBNuvation Bio-$727.00K
CSBRChampions Oncology-$-14.06M

LBPH Revenue FAQ

What is Longboard Pharmaceuticals’s yearly revenue?

Longboard Pharmaceuticals's yearly revenue for 2023 was $0, representing an increase of 100.00% compared to 2022. The company's yearly revenue for 2022 was $0, representing an increase of 100.00% compared to 2021. LBPH's yearly revenue for 2021 was $0, representing an increase of 100.00% compared to 2020.

What is Longboard Pharmaceuticals’s quarterly revenue?

Longboard Pharmaceuticals's quarterly revenue for Q3 2024 was $0, a 100.00% increase from the previous quarter (Q2 2024), and a 0% increase year-over-year (Q3 2023). The company's quarterly revenue for Q2 2024 was $0, a 100.00% increase from the previous quarter (Q1 2024), and a 0% increase year-over-year (Q2 2023). LBPH's quarterly revenue for Q1 2024 was $0, a -100.00% decrease from the previous quarter (Q4 2023), and a 0% increase year-over-year (Q1 2023).

What is Longboard Pharmaceuticals’s revenue growth rate?

Longboard Pharmaceuticals's revenue growth rate for the last 3 years (2021-2023) was 0%